The use of tick salivary proteins as novel therapeutics

39Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

The last three decades of research into tick salivary components have revealed several proteins with important pharmacological and immunological activities. Two primary interests have driven research into tick salivary secretions: The search for suitable pathogen transmission blocking or "anti-tick" vaccine candidates and the search for novel therapeutics derived from tick salivary components. Intensive basic research in the field of tick salivary gland transcriptomics and proteomics has identified several major protein families that play important roles in tick feeding and overcoming vertebrate anti-tick responses. Moreover, these families contain members with unrealized therapeutic potential. Here we review the major tick salivary protein families exploitable in medical applications such as immunomodulation, inhibition of hemostasis and inflammation. Moreover, we discuss the potential, opportunities, and challenges in searching for novel tick-derived drugs.

Cite

CITATION STYLE

APA

Chmelar, J., Kotál, J., Kovaríková, A., & Kotsyfakis, M. (2019). The use of tick salivary proteins as novel therapeutics. Frontiers in Physiology. Frontiers Media S.A. https://doi.org/10.3389/fphys.2019.00812

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free